Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B

<div>Reducing fractional excretion of phosphate (FEPO<sub>4</sub>) and uric acid (FEUA) from baseline to one year after discontinuation of nucleotide analogue therapy. (a) FEPO<sub>4</sub> and (b) FEUA.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B 